1. Home
  2. HUMA vs CTLP Comparison

HUMA vs CTLP Comparison

Compare HUMA & CTLP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HUMA
  • CTLP
  • Stock Information
  • Founded
  • HUMA 2004
  • CTLP 1992
  • Country
  • HUMA United States
  • CTLP United States
  • Employees
  • HUMA N/A
  • CTLP N/A
  • Industry
  • HUMA Biotechnology: Pharmaceutical Preparations
  • CTLP EDP Services
  • Sector
  • HUMA Health Care
  • CTLP Technology
  • Exchange
  • HUMA Nasdaq
  • CTLP Nasdaq
  • Market Cap
  • HUMA 679.3M
  • CTLP 684.6M
  • IPO Year
  • HUMA N/A
  • CTLP N/A
  • Fundamental
  • Price
  • HUMA $5.26
  • CTLP $9.32
  • Analyst Decision
  • HUMA Strong Buy
  • CTLP Strong Buy
  • Analyst Count
  • HUMA 8
  • CTLP 4
  • Target Price
  • HUMA $11.50
  • CTLP $10.25
  • AVG Volume (30 Days)
  • HUMA 3.2M
  • CTLP 366.1K
  • Earning Date
  • HUMA 11-08-2024
  • CTLP 11-07-2024
  • Dividend Yield
  • HUMA N/A
  • CTLP N/A
  • EPS Growth
  • HUMA N/A
  • CTLP 109389.05
  • EPS
  • HUMA N/A
  • CTLP 0.15
  • Revenue
  • HUMA N/A
  • CTLP $268,596,000.00
  • Revenue This Year
  • HUMA N/A
  • CTLP $18.91
  • Revenue Next Year
  • HUMA $4,615.69
  • CTLP $14.86
  • P/E Ratio
  • HUMA N/A
  • CTLP $62.13
  • Revenue Growth
  • HUMA N/A
  • CTLP 10.24
  • 52 Week Low
  • HUMA $2.08
  • CTLP $5.75
  • 52 Week High
  • HUMA $9.97
  • CTLP $9.67
  • Technical
  • Relative Strength Index (RSI)
  • HUMA 47.00
  • CTLP 66.89
  • Support Level
  • HUMA $5.06
  • CTLP $8.86
  • Resistance Level
  • HUMA $5.63
  • CTLP $9.67
  • Average True Range (ATR)
  • HUMA 0.34
  • CTLP 0.26
  • MACD
  • HUMA 0.00
  • CTLP -0.05
  • Stochastic Oscillator
  • HUMA 35.65
  • CTLP 60.23

About HUMA Humacyte Inc.

Humacyte Inc is developing a disruptive biotechnology platform to deliver universally implantable bioengineered human tissues and organs designed to improve the lives of patients and transform the practice of medicine. It develops and manufactures acellular tissues to treat a wide range of diseases, injuries, and chronic conditions.

About CTLP Cantaloupe Inc.

Cantaloupe Inc operates in the small ticket electronic payments industry. It provides wireless, cashless, micro-transactions, and networking services within the unattended Point of Sale (POS) market. Its products and services portfolio consists of ePort Cashless devices, eSuds, EnergyMisers, and Value-added services which include Loyalty and Prepaid, Intelligent Vending, and others. The company offers services to different industries covering car wash, taxi and transportation, laundry, vending, kiosk, amusement, and arcade. The company derives revenue from the sale or lease of equipment and services to the small ticket, unattended POS market, and the majority of its revenue is derived from subscription and transaction fees.

Share on Social Networks: